Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 7, 2014

Primary Completion Date

May 9, 2022

Study Completion Date

May 9, 2022

Conditions
Heart Failure With a Preserved Ejection FractionHeart Failure, DiastolicChronotropic Incompetence
Interventions
DEVICE

Rate adaptive atrial pacing using a dual-chamber pacemaker

The Azure XT DR is a permanent, dual-chamber cardiac pacemaker with the ability to continuously monitor and record patient activity, and respond to activity by pacing faster and increasing the heart rate (rate adaptive atrial pacing). It will be programmed in AAIR mode to pace the right atrium. The leads will be placed in the right atrium and right ventricle using CapSureFix model 5086.

DEVICE

Pacemaker system will be implanted but set to Pacing Off.

The identical pacing system will be implanted, but will be set to Pacing Off.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Mayo Clinic

OTHER

NCT02145351 - Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure | Biotech Hunter | Biotech Hunter